Breeze Meds vs Hers: Which GLP-1 Provider Is Better?
Short answer: Breeze Meds and Hers tie at 7.3/10 on our rubric, so the decision comes down to price and format rather than overall quality. Full reasoning, pricing and the cases where the other one wins are below.
Breeze Meds and Hers are tied at 7.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Hers is $188 first month, then $298/mo. Choose Breeze Meds for users who want to order compounded glp-1s month-by-month with no subscription commitment. Choose Hers for women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path.
A side-by-side look at Breeze Meds and Hers to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Breeze Meds
#29 of 54Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsHers
#30 of 54The women's health arm of Hims & Hers Health (NYSE: HIMS). Hers lists Wegovy pill, Foundayo, and Ozempic pill medication from $149, a Wegovy pen from $199, Zepbound from $299, and compounded options. A required Weight Loss Membership adds $39 in month one and $149/mo thereafter, so the all-in floor for a $149 medication path is $188 initially and $298/mo ongoing; exact product and dose prices vary.
Visit Hers| Feature | Breeze Meds | Hers |
|---|---|---|
| Why each one | No subscription required, pay per order rather than committing to recurring billing, with three formulation options including oral tablets. | A major women-focused telehealth platform with a direct Novo Nordisk partnership (Wegovy pill from $149 and pen from $199 before required membership) and a Lilly partnership (Zepbound medication from $299) alongside compounded options. |
| Our Score | 7.3/10 | 7.3/10 |
| Headline Price | from $199/mo | $188 first month, then $298/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want to order compounded GLP-1s month-by-month with no subscription commitment | Women who want a female-focused platform and can budget at least $188 initially and $298/mo ongoing for a $149 medication path |
| Watch out for | Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment. | Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings. |
| Ranking | #29 | #30 |
| Get started | Visit Breeze Meds | Visit Hers |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required, order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Independent reviews are very limited and the company structure is unclear, so legitimacy is hard to verify. Ask for pharmacy details first; the no-subscription model at least keeps a first order low-commitment.
- −Oral options at $299-399/mo cost significantly more than injectable alternatives. The $199 injectable semaglutide is the value pick unless tablets are a must.
- −Not available in all 50 states; availability depends on provider licensure, so check your state early in the online visit.
Hers
Pros
- +FDA-approved brand paths include Wegovy pill, Foundayo, and Ozempic pill medication from $149 and a Wegovy pen from $199; with the required membership, a $149 medication path totals $188 initially and $298/mo ongoing
- +Zepbound access via the Lilly/Hims-Hers partnership announced 2026
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Broader women's health platform, integrates weight loss with hormonal, skin, and wellness services
Cons
- −Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
- −Every medication figure excludes the required Weight Loss Membership ($39 first month, then $149/mo); exact product and dose prices can increase the total above the $188/$298 floor
- −Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
- −Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
- −Zepbound medication starts at $299 before the required membership; that path totals $338 in month one and at least $448/mo ongoing, with exact dose pricing potentially higher
Our Verdict
Breeze Meds and Hers are closely matched with identical scores of 7.3/10. Published pricing is not a like-for-like monthly comparison: Breeze Meds is from $199/mo; Hers is $188 first month, then $298/mo. Hers offers both brand-name and compounded medications, giving you more flexibility.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Breeze Meds and Hers.
Not comparing, just asking? Quick answers to the most-asked GLP-1 questions →
- Breeze Meds vs Direct Meds GLP-1from $297/mo
- Breeze Meds vs DudeMedsfrom $149/mo
- Breeze Meds vs PeterMDfrom $165/mo
- Hers vs Ivim Healthfrom $150/mo
- Hers vs Calibratepublished $199/mo; total not verified
- Hers vs bmiMD$289/mo month-to-month
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.